Dr. Mothaffar Rimawi recognized for outstanding contributions to breast cancer Jun 23, 2015 Dr. Mothaffar Rimawi, director of the Lester and Sue Smith Breast Center, received the C. Kent Osborne Award for Medical Excellence for his contributions to breast cancer research.
Mother's diet before pregnancy may affect child’s lifelong risk of cancer Jun 11, 2015 Study finds mother’s diet around the time of conception can change the function of certain genes in her child, including the gene associated with cancer risk.
Baylor College of Medicine's Duncan Cancer Center receives additional $15.9 million in state cancer funding May 29, 2015 Researchers in the NCI-designated Dan L Duncan Cancer Center at Baylor College of Medicine have received $15.9 million from the Cancer Prevention and Research Institute of Texas for two new large grants focused on liver cancer and prostate cancer.
Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatment May 12, 2015 Baylor researchers find a human growth factor that expands white blood cells in response to infection also acts on neuroblastoma cancer stem cells that are thought responsible for disease relapse.
IL-33 promotes colorectal cancer tumor-growing environment Apr 27, 2015 Researchers from Baylor College of Medicine have unlocked new clues about how the colorectal cancer tumor microenvironment is formed and regulated.
Baylor receives Avon Foundation grants for research, community care Apr 27, 2015 Baylor College of Medicine has received two new grants totaling $325,000 from the Avon Foundation for Women that will help its physicians and researchers continue to improve access to life-saving breast cancer prevention and treatment resources.
Enzyme cuts path for T-cells to fight solid tumors Apr 13, 2015 T-cells specifically engineered to express enzyme heparanase have an improved ability to infiltrate the extracellular matrix surrounding solid tumors.
First evaluation of HER2-specific ‘killer’ T cells in humans Mar 23, 2015 A clinical trial has shown promise for a new type of immunotherapy treatment for patients with HER2-positive sarcoma and may extend to other types of cancer.
Incorporate genetic evaluation in familial colorectal cancer screening Mar 18, 2015 Have a family history of colorectal cancer? Incorporate a genetics evaluation into a more proactive screening approach.
Fusion gene provides a biological marker and clue for ovarian cancer Mar 10, 2015 Baylor researchers find a fusion gene may provide a clue and a marker for identifying a sub-group of the most common form of ovarian cancer.